Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001172661-26-005299
Filing Date
2026-11-16
Accepted
2026-11-16 14:01:36
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 7845
  Complete submission text file 0001172661-26-005299.txt   9666
Mailing Address 200 CLARENDON STREET 50TH FLOOR BOSTON MA 02116
Business Address 200 CLARENDON STREET 50TH FLOOR BOSTON MA 02116 857-702-0388
Cormorant Asset Management, LP (Filed by) CIK: 0001583977 (see all company filings)

EIN.: 462108927 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A

Mailing Address 99 HIGH STREET SUITE 2100 BOSTON MA 02110
Business Address 99 HIGH STREET SUITE 2100 BOSTON MA 02110 857-321-8020
Rapport Therapeutics, Inc. (Subject) CIK: 0002012593 (see all company filings)

EIN.: 880724208 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-94532 | Film No.: 261559155
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)